AU Patent

AU2010321874A1 — Oral formulation for dexlansoprazole

Assigned to Handa Pharmaceuticals LLC · Expires 2012-06-21 · 14y expired

What this patent protects

A stable formulation of dexlansoprazole for treating a digestive disorder, and methods of manufacturing the same.

USPTO Abstract

A stable formulation of dexlansoprazole for treating a digestive disorder, and methods of manufacturing the same.

Drugs covered by this patent

Patent Metadata

Patent number
AU2010321874A1
Jurisdiction
AU
Classification
—
Expires
2012-06-21
Drug substance claim
No
Drug product claim
No
Assignee
Handa Pharmaceuticals LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.